X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (25) 25
hiv (24) 24
humans (22) 22
infectious diseases (22) 22
human immunodeficiency virus--hiv (21) 21
female (20) 20
male (19) 19
article (16) 16
adult (15) 15
immunology (15) 15
viral load (13) 13
antiretroviral therapy (12) 12
drug therapy (11) 11
hiv infections - drug therapy (11) 11
prevention (11) 11
antiretroviral drugs (10) 10
clinical trials (10) 10
infection (10) 10
therapy (10) 10
acquired immune deficiency syndrome--aids (9) 9
cd4 lymphocyte count (9) 9
hiv infection (9) 9
antiviral agents (8) 8
disease prevention (8) 8
hiv infections - virology (8) 8
hptn 052 (8) 8
infections (8) 8
aids (7) 7
drug resistance (7) 7
hiv-1 (7) 7
men (7) 7
risk (7) 7
south africa (7) 7
virology (7) 7
young adult (7) 7
cd4 antigen (6) 6
microbiology (6) 6
research (6) 6
abridged index medicus (5) 5
adults (5) 5
aids/hiv (5) 5
anti-hiv agents - therapeutic use (5) 5
anti-retroviral agents - therapeutic use (5) 5
antiretroviral agents (5) 5
disease progression (5) 5
disease transmission (5) 5
dosage and administration (5) 5
drug administration schedule (5) 5
early art (5) 5
hiv infections - diagnosis (5) 5
hiv infections - immunology (5) 5
human immunodeficiency virus (5) 5
infant (5) 5
medicine, general & internal (5) 5
public health (5) 5
resistance (5) 5
sex (5) 5
transmission (5) 5
treatment outcome (5) 5
virus diseases (5) 5
acquired immune deficiency syndrome (4) 4
adolescent (4) 4
africa (4) 4
age (4) 4
biology and life sciences (4) 4
children (4) 4
hiv infections - epidemiology (4) 4
hiv infections - prevention & control (4) 4
hiv infections - transmission (4) 4
hiv patients (4) 4
infants (4) 4
medicine (4) 4
medicine and health sciences (4) 4
middle aged (4) 4
mortality (4) 4
pharmacology (4) 4
pre-exposure prophylaxis (4) 4
preexposure prophylaxis (4) 4
research article (4) 4
risk factors (4) 4
sexually transmitted diseases (4) 4
treatment failure (4) 4
viruses (4) 4
anti-retroviral agents - administration & dosage (3) 3
antiretrovirals (3) 3
care and treatment (3) 3
cohort studies (3) 3
confidence intervals (3) 3
deoxyribonucleic acid--dna (3) 3
diagnosis (3) 3
disease (3) 3
drugs (3) 3
health aspects (3) 3
health risks (3) 3
hiv prevention (3) 3
hiv testing (3) 3
hiv-1 - isolation & purification (3) 3
immunodeficiency viruses (3) 3
impact (3) 3
infant, newborn (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 4, pp. 281 - 290
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9904, pp. 1555 - 1563
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 9, pp. 830 - 839
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9734, pp. 33 - 40
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 18, pp. 1715 - 1725
Journal Article
PLoS medicine, ISSN 1549-1277, 11/2018, Volume 15, Issue 11, p. e1002690
Background Cabotegravir (CAB) is a novel strand-transfer integrase inhibitor being developed for HIV treatment and prevention. CAB is formulated both as an... 
MEDICINE, GENERAL & INTERNAL | MEN | PREVENTION | ADULTS | RILPIVIRINE | PREEXPOSURE PROPHYLAXIS | PROTECTS MACAQUES | HIV Infections - prevention & control | United States | Humans | Middle Aged | Male | Pyridones - blood | Anti-HIV Agents - administration & dosage | Young Adult | Pyridones - administration & dosage | Malawi | HIV Infections - diagnosis | Brazil | Adult | Female | HIV Infections - transmission | Anti-HIV Agents - blood | Double-Blind Method | Drug Administration Schedule | Pyridones - pharmacokinetics | Risk Assessment | Anti-HIV Agents - adverse effects | HIV Infections - virology | Risk Factors | Treatment Outcome | Injections, Intramuscular | Anti-HIV Agents - pharmacokinetics | Adolescent | South Africa | Aged | Drug Monitoring | Delayed-Action Preparations | Pyridones - adverse effects | Prevention | Tenofovir | Usage | Safety and security measures | Analysis | Clinical trials | Pharmacokinetics | HIV infection | Drug delivery systems | Sexually transmitted diseases--STD | Funding | Risk | Population studies | Infections | Males | Randomization | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Safety | Supervision | Integrase | Medical research | Risk groups | Population characteristics | Health risks | Pharmacology | Injection | Medicine | Disease prevention | Infectious diseases | Men | Software | Females | Cancer | STD | Sexually transmitted diseases | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 11/2013, Volume 208, Issue 10, pp. 1624 - 1628
Journal Article